Financing led by Novartis Venture Fund and Forbion, with new investment from Omega Funds, Droia Ventures, YK Bioventures, and Digitalis Ventures Renewed backing from Vida Ventures, MPM BioImpact, Lightspeed Venture Partners, and Scripps Research SAN DIEGO, Dec. 1, 2025 /PRNewswire/ –…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
